Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Two Experimental Oral Rinses for Dentinal Hypersensitivity
NCT02542943Completed
- Sponsor
- GSK
- Start
- Sep 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dipotassium oxalate in dentin hypersensitivity (DH) (3 arms), sponsored by GSK. Primary endpoint: Change From Baseline in Schiff Sensitivity Score at 8 weeks. Started Sep 2015; status: completed.
02
Drugs
dipotassium oxalate
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT02542943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02542943.